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CD98, an early marker of T-cell activation, is an important regulator of integrin-mediated
adhesion events. Previous studies suggest that CD98 is coupled to both cellular activation and
transformation and is involved in the pathogenesis of viral infection, inflammatory disease, and
cancer. Understanding of the molecular mechanisms underlying CD98 activity may have far-
reaching practical applications in the development of novel therapeutic strategies in these disease
states. Using small cell lung cancer cell lines, which are nonadherent, nonpolarized, and highly
express CD98, we show that, in vitro, under physiological conditions, CD98 is constitutively
associated with 1 integrins regardless of activation status. Cross-linking CD98 with the mono-
clonal antibody 4F2 stimulated phosphatidylinositol (PI) 3-kinase, PI(3,4,5)P3, and protein kinase
B in the absence of integrin ligation or extracellular matrix engagement. Furthermore, cross-
linking CD98 promoted anchorage-independent growth. Using fibroblasts derived from 1 inte-
grin null stem cells (GD25), wild-type GD251, or GD25 cells expressing a mutation preventing 1
integrin-dependent FAK phosphorylation, we demonstrate that a functional 1 integrin is re-
quired for CD98 signaling. We propose that by cross-linking CD98, it acts as a “molecular
facilitator” in the plasma membrane, clustering 1 integrins to form high-density complexes. This
results in integrin activation, integrin-like signaling, and anchorage-independent growth. Activa-
tion of PI 3-kinase may, in part, explain cellular transformation seen on overexpressing CD98.
These results may provide a paradigm for events involved in such diverse processes as inflam-
mation and viral-induced cell fusion.
INTRODUCTION
CD98 is a disulfide-linked 125-kDa heterodimeric type II
transmembrane glycoprotein composed of a glycosylated
85-kDa heavy chain (designated CD98) and a nonglycosy-
lated 40-kDa light chain. Early studies of peripheral blood T
lymphocytes implicated CD98 in the regulation of cellular
activation but did not define a specific function for this
antigen (Haynes et al., 1981). CD98 is expressed ubiquitously
and highly conserved between species. Although it is ex-
pressed at low levels on the surface of quiescent cells CD98
expression is rapidly up-regulated after cellular activation
(Azzarone et al., 1985; Suomalainen, 1986; Parmacek et al.,
1989). For instance, CD98 is strongly expressed on human
embryonic and newborn fibroblasts but expression gradu-
ally diminishes from 100 to 1% on fibroblasts from normal
adults (Azzarone et al., 1985). CD98 is reconstituted to high
levels on many tumor cell types (Bellone et al., 1989; Dixon et
al., 1990) and furthermore, overexpression of CD98 on
NIH3T3 cells has been shown to result in cellular transfor-
mation (Hara et al., 1999). These expression patterns suggest
that the function of CD98 is coupled to cellular activation,
although a definitive role and mechanism of action have yet
to be described.
Previous studies suggested that an intracellular signaling
pathway mediates the action of CD98 (Warren et al., 1996;
Okamoto et al., 1997; Tabata et al., 1997). Tyrosine kinase
inhibitors inhibit CD98 activity in hematopoietic cells, sug-
gesting that tyrosine kinase activation may be an early signal
transduction pathway activated by CD98 (Warren et al.,
1996). There is also evidence that CD98 is involved in the
regulation of intracellular calcium concentration through the
Na/Ca2 exchanger, although its effect seems to be cell
type specific (Michalak et al., 1986; Posillico et al., 1987;
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Freidman et al., 1994). Although six alternative CD98 asso-
ciated light chains have been identified to date, four of
which are associated with L-type amino acid transport ac-
tivity (Verrey et al., 1999), there seems to be only a single
heavy chain, which has been demonstrated to act as a
unique and highly specific regulator of integrin affinity
(Fenczik et al., 1997). It has been shown previously that 1
integrin-mediated adhesion of the SCLC cell line H345 to
fibronectin and laminin can be markedly up-regulated by
cross-linking CD98 (Fenczik et al., 1997). In addition, CD98
has been shown to stimulate adhesion of breast cancer cells
to laminin via the integrin 31 (Chandrasekaran et al.,
1999).
Monocytes/macrophages are a key cell type in the control
of inflammatory processes and CD98 has a critical role in the
functional reprogramming of monocyte behavior. Anti-
CD98 monoclonal antibody (mAb) promotes monocyte–
monocyte interactions that ultimately lead to polykaryon
(multinucleated giant cell) formation, a phenotype associ-
ated with chronic inflammatory conditions. Compelling ev-
idence also exists for a connection between CD98 and virus-
induced cell fusion. Antibodies to the heavy chain of CD98
promote cell fusion induced by Newcastle disease virus and
by the gp160 envelope glycoprotein of human immunode-
ficiency virus (Ito et al., 1992; Ohgimoto et al., 1995).
In vitro binding studies have shown that CD98 heavy
chain interacts specifically with the integrin 1A but not
with the muscle-specific variant 1D, or the leukocyte-spe-
cific 7 cytoplasmic domain (Zent et al., 2000). Because 1A
integrins are mostly expressed basolaterally in polarized
cells, and 1D and 7 are expressed in nonpolarized cells, it
has been speculated that interactions between CD98 and 1
integrins may influence the polarization state of epithelial
cells (Merlin et al., 2001). Integrins are required for normal
epithelial development, and abnormal regulation of integrin
function may result in deranged growth control and altered
epithelial cell function.
Thus, mounting evidence suggests that CD98 may be
important in cancer, inflammation, and viral disease
through its effects on cellular activation and inte-
grin-mediated adhesion. Therefore, an understanding of the
mechanisms and biological relevance of CD98 function may
have far-reaching practical applications for the development
of novel therapies in these disease states. The aim of this
study was to explore the molecular mechanisms by which
CD98 regulates integrin activation and integrin-mediated
adhesion events as well as cellular activation and transfor-
mation.
MATERIALS AND METHODS
Cell Culture and Antibody Production
NCI-H69, NCI-H345, and NCI-H510 human SCLC cell lines were
purchased from the American Type Culture Collection (Rockville,
MD.). All SCLC cell lines were maintained in RPMI 1640 containing
25 mM HEPES supplemented with 10% (vol/vol) fetal bovine se-
rum (FBS) (heat-inactivated at 57°C for 1 h). Before experimentation,
SCLC cells were removed from culture medium, washed twice, and
cultured for 24 h in either serum-free medium or in quiescent
medium. Serum-free medium was made up of RPMI 1640 medium
containing 25 mM HEPES supplemented with 30 nM selenium, 5
g/ml insulin, 10 g/ml transferrin, and 0.25% (wt/vol) bovine
serum albumin (BSA) (SITA). Quiescent medium was made up of
RPMI 1640 medium containing 25 mM HEPES supplemented with
0.25% BSA. All media contained 50 U/ml penicillin, 50 g/ml
streptomycin, and 5 g/ml l-glutamine, and all cell lines were
maintained in a humidified atmosphere of 5% CO2, 95% air at 37°C.
Chinese hamster ovary (CHO)-K1 cells were obtained from the
American Type Culture Collection and were grown in DMEM con-
taining 10% FBS, 1% nonessential amino acids, 5 g/ml glutamine,
50 U/ml penicillin, and 50 g/ml streptomycin. The cell lines GD25,
GD251A, and GD251AY783/795F have been described previously
(Fassler et al., 1995; Sakai et al., 1998). The GD25 cells are fibroblasts
derived from 1 null stem cells. The GD251A and GD251AY783/
795F mutant cell lines were derived from GD25 cells upon stable
transfection with cDNAs encoding the wild-type and mutated mu-
rine integrin subunit 1A, respectively. GD251AY783/795F cells have
been shown to have a defect in 1 integrin-dependent FAK phos-
phorylation and activation (Wennerberg et al., 2000). GD25 cells
were grown in DMEM containing 10% FBS, 5 g/ml glutamine, 50
U/ml penicillin, and 50 g/ml streptomycin; GD251A and
GD251AY783/795F cells were grown in the same medium containing
10 g/ml puromycin for selection. Transient transfection of the
GD25 cell lines with full-length human CD98 was undertaken using
LipofectAMINE Plus (Invitrogen, Groningen, The Netherlands) as
per manufacturer’s instructions. Under optimal conditions a trans-
fection efficiency of at least 60% was achieved in each cell line.
Control cells were transfected with control vector pcDNA 3.1.
The hybridoma cell lines 4F2 (C13) and TS2.16.2.1 were purchased
from the American Type Culture Collection and cultured in DMEM
containing 15% FBS, 50 U/ml penicillin, 50 g/ml streptomycin,
and 2 mM l-glutamine and OPI media supplement (Sigma-Aldrich,
St. Louis, MO). Secreted antibody was purified using protein A
affinity chromatography. F(ab)2 fragments were prepared by pep-
sin digestion of purified 4F2 IgG (2 mg/ml) for 6 h at 37°C. Diges-
tion was terminated by adding 1.5 M Tris pH 8.8 to achieve a final
pH 7.5. F(ab)2 fragments were dialyzed against 20 mM Tris/0.14 M
NaCl pH 7.5, and Fab fragments were produced by addition of
l-cysteine to a final concentration of 10 mM. Digestion was termi-
nated by the addition of iodoacetamide. Fab fragments were puri-
fied on protein A-Sepharose columns. Fab fragments were charac-
terized by SDS-PAGE and exhibited characteristic mobility. After
characterization by FACSCalibur (BD Biosciences, San Jose, CA),
4F2 and 4F2-Fab antibodies were routinely used at a final concen-
tration of 20 g/ml.
Flow Cytometry
Aliquots of 5  105 cells were washed and resuspended in 100 l of
phosphate-buffered saline (PBS) containing 0.2% (wt/vol) BSA and
0.1% sodium azide (PBS). Incubation with 4F2 (for CD98) and
9EG7 (for 1 integrin) (BD PharMingen, San Diego, CA) was per-
formed for 30 min at room temperature followed by two washes
with PBS. Samples were then incubated with species appropriate
fluorescein isothiocyanate (FITC)-conjugated secondary antibody
(1:40) (DAKO, Bucks, United Kingdom) for 30 min at 4°C and again
washed twice in PBS. Samples were finally resuspended in PBS and
analyzed by flow cytometry by using FACSCalibur (BD Bio-
sciences). Control IgG2a and IgG1 antibodies for 4F2 and 9EG7,
respectively, were used as indicated in figure legends.
Confocal Immunofluorescence
The following primary monoclonal antibodies were used: 4F2 con-
jugated with Alexa-Fluor 568 (Molecular Probes, Leiden, The Neth-
erlands) (designated 4F2-AR), K20-FITC (DAKO, Glostrup, Den-
mark), 4B4 (Beckman Coulter, Fullerton, CA), TS2/16 conjugated
with FITC (Sigma-Aldrich) (designated TS2/16-FITC), and CD71-
FITC (BD Biosciences). The following secondary and tertiary anti-
bodies were used: to amplify the FITC signal, Alexa-Fluor 488 rabbit
anti-fluorescein and Alexa-Fluor 488 goat anti-rabbit IgG (Molecular
Probes); to localize 4B4, Alexa-Fluor 488 goat anti-mouse IgG (Mo-
R.C. Rintoul et al.
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lecular Probes). Mouse IgG1 and IgG2A antibodies directed against
Aspergillus niger glucose oxidase (DAKO, Bucks, United Kingdom)
were used as negative controls.
To assess the native state of CD98 and 1 integrin, SCLC cells
were plated onto glass coverslips and fixed with 3% paraformalde-
hyde. Formaldehyde groups were quenched by immersing the cov-
erslips in 50 mM NH4Cl. Nonspecific binding sites were then
blocked using 0.2% fish skin gelatin in PBS. Cells were then incu-
bated sequentially with 1) 4F2-AR and K20-FITC or IgG1 and IgG2A
negative control antibodies, 2) secondary anti-fluorescein, and 3)
tertiary anti-rabbit IgG. To assess the effect on colocalization of
cross-linking CD98 with mAb 4F2, primary antibody incubation
with 4F2-AR and K20-FITC was carried out before fixation. Second-
ary and tertiary antibody labeling was performed as described
above. To assess the effect of 1 integrin function-stimulating or 1
integrin function-blocking antibodies, cells were incubated with
TS2/16-FITC and 4B4, respectively, before fixation, and subsequent
secondary and tertiary antibody labeling. In these latter experi-
ments, incubation with 4F2-AR was performed last of all, after
secondary and tertiary labeling of the 1 integrin. As a further
negative control, localization of 4F2-AR and 1 integrin was com-
pared with that of the transferrin receptor (CD71), by using an
isotype-matched (IgG2A) mouse anti-human CD71 antibody (CD71-
FITC). In all experiments cells were gently washed twice with PBS
between steps. Finally, cells were mounted from distilled water in
Mowiol. Confocal microscopy was performed with a TCS NT con-
focal microscope system (Leica, Heidelburg, Germany) and image
analysis was performed using TCS NT software (Leica).
Coimmunoprecipitation
Cells (30  106) were washed with Hanks’ buffered salt solution,
before being lysed using 20 mM HEPES, 150 mM NaCl, 2 mM
MgCl2, 0.5 mM CaCl2, 1% 3-[(3-cholamidopropyl)dimethylammo-
nio]propanesulfonate, and Complete protease inhibitor cocktail
(Roche Applied Science, Mannheim, Germany). Lysates were clari-
fied by centrifugation at 13,000 rpm. To remove nonspecific con-
taminants, lysates were then incubated with 30 l of albumin-
agarose (Sigma-Aldrich) for 30 min. After further centrifugation, the
residual lysates were incubated overnight with 2 g of either 4F2,
mouse anti-human CD71 as a negative control antibody, K20
(DAKO, Bucks, United Kingdom), or a mouse IgG1 negative control
antibody (DAKO, Bucks, United Kingdom). Protein G-agarose (50
l) was used to precipitate the antibodies. Agarose beads were then
washed twice in 20 mM HEPES, 150 mM NaCl, 2 mM MgCl2, and
0.5 mM CaCl2 before being boiled with SDS-PAGE sample buffer.
Samples were run on 10% Sepharose gel and transferred to nitro-
cellulose membrane (Amersham Biosciences UK, Little Chalfont,
Buckinghamshire, United Kingdom). After blocking with 5% nonfat
milk, Western blots were probed with antibody to 1 integrin
(Transduction Laboratories, Lexington, KY) and a secondary anti-
mouse horseradish peroxidase conjugate (DAKO, Bucks, United
Kingdom). Visualization was by enhanced chemiluminescence
(Amersham Biosciences UK).
PI 3-Kinase Activity Assay
PI 3-kinase activity was measured as described previously (Moore
et al., 1998). Briefly, cells were lysed using ice-cold lysis buffer
containing 50 mM HEPES pH 7.4, 150 mM NaCl, 1.5 mM MgCl2, 1
mM EGTA, 10 mM sodium pyrophosphate, 100 mM sodium fluo-
ride, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 0.5 mM
dithiothreitol, 1 mM sodium orthovanadate, 50 M 4-(2-aminoeth-
yl)benzenesulfonyl fluoride, 5 g/ml leupeptin, 20 g/ml aproti-
nin, and 10 g/ml soybean trypsin inhibitor. PI 3-kinase was im-
munoprecipitated from protein-equilibrated cell lysates by using a
specific p85 PI 3-kinase antibody (Upstate Biotechnology, Lake
Placid, NY) and assayed for activity by using [-32P]ATP and phos-
phatidylinositol as substrate. 3-Phosphorylated lipids were resolved
using thin layer chromatography, identified by autoradiography,
and quantified by liquid scintillation counting. The identity of the
PI(3)P was confirmed by monomethylamine deacylation and high-
performance liquid chromatography analysis by using an SAX 5
column and (NH4)2HPO4 gradient and authentic tritiated standards
as markers.
Radioligand Displacement Assay for Mass
Measurement of PI(3,4,5)P3
PI(3,4,5)P3 levels were measured as described previously (van der
Kaay et al., 1999). In brief, SCLC cells (5  106) were subjected to a
standard Folch extraction, and lipid extracts containing PI(3,4,5)P3
were then subjected to alkaline hydrolysis, resulting in the release of
the polar head group Ins(1,3,4,5)P4. The mass of Ins(1,3,4,5)P4 was
measured by [3H]Ins(1,3,4,5)P4 displacement from a recombinant
Ins(1,3,4,5)P4-GST binding protein, by using a calibration curve
obtained using unlabeled Ins(1,3,4,5)P4 standards.
Protein Kinase B Activity Assay
Protein kinase B activity (PKB) was measured as described previ-
ously (Moore et al., 1998). In brief, PKB was immunoprecipitated
from cell lysates by using an anti-PKB PH-domain antibody (Up-
state Biotechnology) preconjugated to 5 l of protein G-Sepharose.
PKB activity was assayed by incubating washed immunoprecipi-
tates with [-32P]ATP and Cross-tide (Upstate Biotechnology) as
substrate. The assays were terminated by placing the assay mixture
onto P8l Whatman chromatography paper (Whatman, Maidstone,
United Kingdom) and washing four times with 0.5% (vol/vol)
phosphoric acid and once with acetone. Radioactive incorporation
was quantified by liquid scintillation counting.
Amino Acid Transport Assay
Cells (5  106) were washed twice and resuspended in amino
acid-free and Na-free uptake solution containing 100 mM choline
chloride, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES
pH 7.5. After equilibration at 37°C for 30 min cells were treated for
a further 10 min with or without 4F2 (20 g/ml) in the presence or
absence of 5 mM 2-amino-2-norbornanecarboxylic acid (BCH) (Sig-
ma-Aldrich). After this, 2 Ci of l-[4,5-3H]leucine (82 Ci/mmol)
containing 2 mM cold l-leucine was added to each tube and incu-
bation continued for a further 30 min at 37°C. Cells were then placed
on ice, pelleted, and washed three times with 1 ml of ice-cold wash
buffer containing 80 M choline chloride, 2 mM KCl, 1 mM MgCl2,
1 mM CaCl2, and 10 mM HEPES pH 7.5. The washed cells were then
digested with 200 l 0.2% SDS in 0.2 M NaOH for 1 h. Protein
equilibrated aliquots of 100 l were then added to scintillation fluid
containing 100 l of 0.2 M HCl and activity counted in a scintillation
counter.
Immunoblotting
Cell pellets were lysed at 4°C in PI 3-kinase lysis buffer for 30 min.
Lysates were clarified by centrifugation at 13,000  g for 10 min at
4°C. Samples (20 g of protein) were solubilized in SDS-PAGE
sample buffer and resolved on 10% gels. The proteins were trans-
ferred to nitrocellulose membranes, blocked using 3% (wt/vol)
albumin in Tris-buffered saline/Tween (20 mM Tris-HCl pH 7.4, 150
mM NaCl, and 0.02% [vol/vol] Tween 20) overnight at 4°C and then
incubated with anti-PKB or anti-phospho PKB (serine 473) antibody
(New England Biolabs, Beverly, MA), anti-FAK or anti-phospho
FAK antibody (Santa Cruz Biotechnology, Santa Cruz, CA), or goat
anti-CD98 antibody (SC-7095) (Santa Cruz Biotechnology). Species
appropriate horseradish peroxidase-conjugated antibodies (DAKO,
Bucks, United Kingdom) were used for secondary labeling. Immu-
noreactive bands were identified using enhanced chemilumines-
cence (Amersham Biosciences UK) according to the manufacturer’s
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instruction. Densitometry was performed using Grab-IT gel docu-
mentation system (Ultra Violet Products, Cambridge, United King-
dom). Using different exposures, blots were confirmed to be within
the dynamic range of the film before analysis.
Clonogenic Assay
SCLC cells, 5 d postpassage, were washed and subsequently incu-
bated in serum-free SITA medium for 24 h. Before experimentation
cells were washed twice and resuspended in fresh SITA medium
before being gently disaggregated as described above. Viability was
determined by trypan blue exclusion on a hemocytometer. Cells
(1 104) were mixed with SITA containing 0.3% (wt/vol) agarose in
the presence or absence of agonist/antagonist and layered over a
solid base of 0.5% (wt/vol) agarose in SITA. The cultures were
incubated in a humidified atmosphere of 5% CO2, 95% air at 37°C
for 21 d and then stained with the vital stain nitro-blue tetrazolium.
Colonies of 16 cells were counted with a microscope.
Statistical Analysis
Data were analyzed by one-way analysis of variance with compar-
ison between groups made using the Newman-Keuls procedure. P
values  0.05 were considered to be significant
RESULTS
CD98 Is Highly Expressed on SCLC Cells In Vitro
CD98 expression on SCLC cell lines in vitro was examined.
CD98 expression was determined by flow cytometric anal-
ysis by using an indirect immunofluorescence technique
with the mAb 4F2 directed against the heavy chain of CD98.
Figure 1A shows CD98 expression on H69 SCLC cells. Mean
fluorescence intensity was 79.4 arbitrary units compared
with an IgG2A isotype-matched control of 14.2 arbitrary
units. When H69 SCLC cells were incubated in the presence
of increasing concentrations of 4F2, a dose-dependent in-
crease in binding was seen with a half-maximal value of 6.5
g/ml (Figure 1B). Saturated binding occurred between 10
and 30 g/ml (Figure 1B).
We confirmed CD98 expression in H69 SCLC cells by
using Western blot analysis of whole cell lysates that had
been probed with an antibody for CD98 and showed a
strong band at85 kDa corresponding with the heavy chain
of CD98. Similar levels of expression of CD98 were also seen
in all other SCLC cell lines examined, including H345 (Fig-
ure 1C) and H510, LS274, LS310, WX330, and GLC19 (our
unpublished data). For control purposes, expression of
CD98 in our SCLC cell lines was compared with that in
CHO-K1 cells. This cell line normally expresses CD98 at low
levels but can be transfected with human CD98, resulting in
cells that show high expression. CD98 transfected and un-
transfected CHO cells were used as positive and negative
controls respectively (Figure 1C).
CD98 and 1 Integrins Coimmunoprecipitate
CD98 was immunoprecipitated from H69 SCLC whole cell
lysates by using 4F2 and appropriate control antibodies as
described in MATERIALS AND METHODS. Western blots
were probed for 1 integrin. Figure 1D shows that upon
immunoprecipitation by 4F2, a band was visualized at 130
kDa (lane 1). This was not seen in immunoprecipitation with
CD71 control antibody (lane 2), or with control IgG1 anti-
body (lane 4), but was clearly seen with immunoprecipita-
tion by the 1 integrin antibody K20 (lane 3). This band
corresponds to 1 integrin.
CD98 and 1 Integrins Are Constitutively
Associated
We used dual label confocal immunofluorescence to exam-
ine the physical relationship between 1 integrins and CD98
in vivo in nonpolarized, nonadherent H69 cells. In the un-
stimulated native state, CD98 (labeled by 4F2) and 1 inte-
grin (labeled by K20 mAb) were colocalized in the plasma
membrane of the cell (Figure 2A). When 4F2 was used to
cross-link and stimulate CD98 before fixation and antibody
labeling, colocalization was again seen (Figure 2B). Further-
more, when cells were incubated with the 1 inte-
grin-stimulating antibody (TS2/16) before fixation, colocal-
ization between 1 integrin and CD98 was still apparent
(Figure 2C). Colocalization was still present in the presence
of a 1 integrin function-blocking antibody (4B4) (our un-
published data). However, no colocalization was seen be-
tween CD98 and another constitutively expressed plasma
membrane protein, the transferrin receptor (CD71) (Figure
2D), nor between CD71 and 1 integrin (our unpublished
data), confirming that the relationship between CD98 and 1
integrin is specific. IgG1 and IgG2A negative control antibod-
Figure 1. CD98 expression in SCLC cells. (A) CD98 expression in
H69 SCLC cells was determined by flow cytometric analysis by
using an indirect immunofluorescence technique with a mAb (4F2)
to the heavy chain of CD98. (B) Dose response for binding of mAb
4F2 to H69 SCLC cells. (C) Western blot analysis of whole cell
lysates that had been probed with goat anti-CD98 polyclonal anti-
body to show CD98 expression on H69 and H345 SCLC cells, native
CHO cells, and CHO cells that had been transiently transfected with
CD98. (D) CD98 and 1 integrin coimmunoprecipitate in SCLC
cells. H69 SCLC whole cell lysates were incubated with antibodies
against CD98 (4F2) (lane 1), transferrin receptor (CD71) (lane 2), 1
integrin (K20) (lane 3), and an IgG1 negative control antibody (lane
4), as described in MATERIALS AND METHODS. Immunoprecipi-
tates were Western blotted and probed for 1 integrin. All data
shown are representative of two to three independent experiments.
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Figure 2. 1 integrin and CD98 are colocalized in SCLC cells. H69 cells were incubated with antibodies against 1 integrin and CD98 as
described in MATERIALS AND METHODS. White bars, 10 m. (A–C) Localization of 1 (green) and CD98 (red) in a single confocal plane
under either (A) native conditions, (B) stimulation by 4F2 cross-linking, and (C) 1 integrin stimulation by using mAb TS2/16. In the
“merged” panel, areas of colocalization of 1 integrin and CD98 appear yellow. (D) Localization of the transferrin receptor was defined by
use of mAb CD71-FITC (green) and CD98 (red) by 4F2-AR. No colocalization between CD98 and CD71 was seen (merged panel). Bottom,
analysis of 1 integrin and CD98 localization along the lines a, b, and c. In contrast, analysis along line d shows no colocalization between
CD98 and CD71.
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ies for 1 and CD98, respectively, revealed no evidence of
nonspecific antibody binding (our unpublished data). These
data demonstrate that CD98 and 1 integrins are physically
colocalized, regardless of integrin activation state and cell
polarization. In addition, these results suggest that 1 inte-
grins and CD98 can form high-density complexes within the
plasma membrane.
Cross-Linking CD98 Stimulates PI 3-Kinase
Activity and PI(3,4,5)P3 Formation
The mechanism of action of CD98 is poorly understood. The
cytoplasmic tail of CD98 seems to be critical for its action
and there is some evidence to suggest that CD98 is involved
in the regulation of intracellular signaling. Therefore, the
effect of cross-linking CD98 on intracellular signaling was
examined. To specifically examine the effect of cross-linking
CD98 the mAb to the heavy chain of CD98 (4F2) was used.
4F2 did not stimulate mobilization of intracellular calcium in
fura-2–loaded SCLC cells (our unpublished data). Because
PI 3-kinase plays a key role in integrin activation, cellular
activation, and transformation (Carpenter and Cantley,
1996) we examined the effect of 4F2 on PI 3-kinase activity in
SCLC cells. PI 3-kinase activity from p85 immunoprecipi-
tates was measured as described in MATERIALS AND
METHODS. Confirmation of equal amounts of PI 3-kinase
loading was obtained by probing Western blots of p85
immunoprecipitates with p85 PI 3-kinase antibody (Figure
3A, top). Figure 3A, bottom, shows that 4F2 (20 g/ml)
caused a 2.5-fold increase in PI 3-kinase activity, first evident
within 2 min, maximal at 5 min, and returning to baseline by
50 min. Similar results were found with the H345 and H510
cell lines (Figure 3A, inset). PI 3-kinase activation by 4F2
could be blocked by preincubation with the PI 3-kinase
inhibitor wortmannin or monovalent Fab-4F2 fragments
(Figure 3B). In addition, the Fab-4F2 monovalent fragments
alone did not have any effect on PI 3-kinase activation,
confirming that cross-linking of CD98 is required for PI
3-kinase activation. Saturating concentrations of an IgG2a
negative control antibody (directed against Aspergillus niger
glucose oxidase) or an IgG2A antibody (10 g/ml) to the
CD71 transferrin receptor, which is highly expressed on
SCLC cells (EC50 of 1.4 g/ml to H69 SCLC cells), had no
effect on PI 3-kinase activity (Figure 3B). Again equal load-
ing of p85 PI 3-kinase immunoprecipitates was confirmed
for all conditions as outlined above (our unpublished data).
Although PI 3-kinase can phosphorylate PI, PI(4)P, and
PI(4,5)P2 in vitro, PI(4,5)P2 is believed to be the preferred
substrate in vivo, generating the second messenger
PI(3,4,5)P3. Therefore, we measured PI(3,4,5)P3 levels by
using a radioisotope dilution assay as described previously
(van der Kaay et al., 1999). Cross-linking of CD98 with 4F2
resulted in a significant increase in PI(3,4,5)P3 compared
with control cells (Figure 4A). This effect could be blocked in
a dose-dependent manner by preincubation with the PI
3-kinase inhibitors wortmannin (IC50 of 3.2 nM) and
LY294002 (IC50 of 1.4 M) (Figure 4B). Again, the anti-CD71
mAb had no effect on PI(3,4,5)P3 levels.
Cross-Linking CD98 Activates Protein Kinase B
In integrin signal transduction, PKB has been identified as a
key downstream effector of PI 3-kinase (Bellacosa et al.,
1991). Therefore, the effect of 4F2 on PKB activity was ex-
amined using an in vitro kinase assay as described in MA-
TERIALS AND METHODS. Figure 5A shows that cross-
linking CD98 with 4F2 antibody stimulated PKB activity in
a time-dependent manner. An increase in PKB activity was
first evident at 2 min, maximal by 10 min, and had returned
to baseline by 20 min. This magnitude of response, and time
course, was very similar to that seen for PI 3-kinase activa-
tion. Again, no effect on PKB activity was seen after incuba-
Figure 3. Cross-linking CD98 activates PI 3-kinase. (A) Time
course of PI 3-kinase activation by 4F2 (20 g/ml). PI 3-kinase was
immunoprecipitated from H69 SCLC cell lysates by using an anti
p85-SH3 antibody. PI 3-kinase was assayed using phosphatidylino-
sitol as substrate. 3-Phosphorylated lipids were resolved using thin
layer chromatography, identified by autoradiography, and quanti-
fied by liquid scintillation counting. An autoradiograph showing
the 3-phosphorylated reaction product [PI(3)P] is shown for a typ-
ical experiment. Equal loading of PI 3-kinase was confirmed by
probing a Western blot of p85 immumoprecipitates with p85 PI
3-kinase antibody (top). Inset, effect of 4F2 (20 g/ml) at 5 min on
PI 3-kinase activity in H345 and H510 SCLC cells (, diluent only).
(B) Cross-linking of CD98 is required for PI 3-kinase activation. H69
cells were treated with 4F2 (20 g/ml), 4F2-Fab (20 g/ml), IgG2A
control antibody (20 g/ml), or antibody to CD71 (10 g/ml),
having been pretreated with wortmannin (100 nM), 4F2-Fab (20
g/ml), or diluent as indicated. PI 3-kinase activity was assayed as
described in MATERIALS AND METHODS. All data are the mean
of three to four independent experiments performed in triplicate 
SEM. *p  0.05 compared with control cells.
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tion of SCLC cells with either Fab-4F2 for 10 min or control
antibodies. These results were confirmed by Western blot-
ting by using a phospho-PKB antibody that recognizes phos-
phorylation of PKB at serine 473. Figure 5B shows that 4F2
caused an increase in phosphorylation of PKB compared
with untreated control or Fab-4F2–treated cells. Further-
more, an anti-mouse IgG F(ab)2 fragment-specific antibody
(Jackson Immunoresearch, West Grove, PA) was able to
restore PKB phosphorylation in Fab-4F2–treated cells con-
firming that cross-linking of CD98 is required for down-
stream signaling. The anti-mouse IgG F(ab)2 fragment-spe-
cific antibody alone had no effect on PKB phosphorylation.
We have also shown that 4F2-induced PKB phosphorylation
can be inhibited in a dose-dependent manner by the PI
3-kinase inhibitors wortmannin and LY294002 (Figure 5C).
Therefore, cross-linking CD98, in addition to activating PI
3-kinase, also activates its principal downstream effector,
PKB. We have also shown that cross-linking CD98 with 4F2
promotes FAK phosphorylation in SCLC cells and CD98-
transfected CHO cells; furthermore, 4F2 stimulation pro-
motes mitogen-activated protein (MAP) kinase activation in
SCLC cells. Moreover, cross-linking CD98 had no effect on
either H-Ras or R-Ras GTP loading/activation (Rintoul,
Mackinnon, and Sethi, unpublished data). Signaling via
FAK, PI 3-kinase, and MAP kinase without activating Ras is
a feature of integrin signaling (King et al., 1997). Taken
together, these results suggest that cross-linking CD98 pro-
motes integrin-like signaling.
Cross-Linking CD98 Has No Effect on Amino Acid
Transport
The light chain of CD98 has been demonstrated to function
as an L-type amino acid transporter. We examined whether
cross-linking CD98 with mAb 4F2 had any effect on amino
acid transport. Using an assay that measures tritiated
leucine uptake into cells, Figure 6 shows that there is no
demonstrable effect of 4F2 on amino acid transport, in the
presence or absence of the L-system amino acid transport
blocking agent BCH. Furthermore, BCH had no effect on PI
3-kinase activation by 4F2 (our unpublished data). These
data show that the effects of 4F2 on integrin-like signaling
are independent of amino acid transport.
Cross-Linking CD98 Promotes Anchorage-
independent Growth
PI 3-kinase and PKB activity play a central role in regulating
cell survival, transformation, and promoting anchorage-in-
dependent growth (Khwaja et al., 1997). The ability to form
colonies in agarose semisolid medium is a hallmark of the
transformed phenotype. There is a positive correlation be-
tween the cloning efficiency of cells and the histological
Figure 4. Cross-linking CD98 stimulates PI(3,4,5)P3. (A) H69 cells
were treated with either diluent (control), 4F2 (20 g/ml for 10
min), wortmannin (WM) (100 nM, 10 min) followed by 4F2 (20
g/ml for 10 min), or antibody to CD71 (10 g/ml for 10 min).
PI(3,4,5)P3 levels were measured by an isotope dilution assay as
described in MATERIALS AND METHODS. (B) H69 SCLC cells
were pretreated with increasing concentrations of the PI 3-kinase
inhibitors wortmannin or LY294002 as shown, followed by 4F2 (20
g/ml for 10 min) and PI(3,4,5)P3 levels measured. All data are the
mean of three independent experiments performed in triplicate 
SEM. *p  0.05 compared with control cells.
Figure 5. Cross-linking CD98 activates PKB.
(A) Time course of PKB activation by 4F2.
PKB was immunoprecipitated from H69 cell
lysates by using an anti-PKB PH-domain an-
tibody. PKB activity was assayed as de-
scribed in MATERIALS AND METHODS.
The figure shows data from a representative
experiment performed in triplicate. (B) West-
ern blot of PKB and phospho-PKB. H69 SCLC
cells were incubated in the presence or ab-
sence of 20 g/ml 4F2 or 4F2-Fab for 10 min
or 4F2-Fab (20 g/ml) for 10 min followed by
an anti-mouse IgG F(ab)2 fragment specific
antibody (20 g/ml) for 20 min (anti-Fab an-
tibody). Western blots were probed with an
antibody, which recognizes PKB or phos-
phorylation of PKB at serine 473 (PKB-P). (C)
H69 SCLC cells were pretreated with increas-
ing concentrations of the PI 3-kinase inhibi-
tors LY294002 or wortmannin as shown, fol-
lowed by 4F2 (20 g/ml for 10 min) and
Western blots were probed with an antibody,
which recognizes PKB or phosphorylation of PKB at serine 473 (PKB-P). Representative blots from experiments performed two to three times
are shown.
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involvement and invasiveness of the tumor in specimens
taken from SCLC (Carney et al., 1980). Therefore, we exam-
ined the functional consequences of cross-linking CD98 with
4F2 in SCLC cells.
Cross-linking CD98 markedly enhanced the ability of
SCLC cell lines H69, H510, and H345 cells to form colonies
in semisolid agarose (Figure 7A). SCLC basal colony growth
can be stimulated 200–300% by the addition of 20 g/ml
4F2. LY294002 inhibited 4F2-stimulated colony formation in
a dose-dependent manner (IC50 of 2.1 M) (Figure 7B),
suggesting that PI 3-kinase activity is required for the CD98
stimulation of anchorage-independent growth in SCLC cells.
Furthermore, addition of maximal clonal-stimulating con-
centrations of neuropeptide growth factors bombesin (10
nM), galanin (50 nM), and bradykinin (10 nM) in H345,
H510, and H69 cell lines, respectively, caused an additive
stimulation of clonal growth (Figure 8).
CD98 Signaling Is 1 Integrin and FAK dependent
The colocalization of CD98 and 1 integrins and CD98-
induced integrin-like signaling and functional effects in
SCLC cells led us to examine whether the presence of 1
integrin was necessary for CD98 signaling. We used GD25
fibroblasts derived from 1 null ES cells and GD251A and
GD251AY783/795F mutant cell lines, derived from GD25
cells upon stable transfection with cDNAs encoding the
wild-type 1A, and 1A integrin subunit with point muta-
tions Y783/795F, respectively. GD251AY783/795F cells have
been shown to have a defect in 1 integrin-dependent FAK
activation (Wennerberg et al., 2000). Using flow cytometry,
we were unable to detect any endogenous CD98 expression
in these cell lines (our unpublished data). Therefore, each
cell line was transiently transfected with full-length human
CD98. Transfection efficiency of 50–60% was achieved in
all cell lines as described in MATERIALS AND METHODS.
Control cells received control vector pcDNA 3.1. 1 integrin
and CD98 expression were confirmed for each cell line by
using flow cytometry (Figure 9A). CD98 signaling was ex-
amined by determining PKB phosphorylation on Western
blotting. In the wild-type GD251A cells, overexpression of
CD98 promoted constitutive PKB and FAK phosphorylation
(Figure 9, B and C). Cross-linking CD98 with 4F2 caused a
Figure 7. Cross-linking CD98 stimulates SCLC clonal growth. (A)
H69, H345, and H510 SCLC cells were plated in SITA medium
containing 0.3% agarose, in the presence or absence of 4F2 (20
g/ml) and LY294002 (10 M) (LY) as shown, over a base of 0.5%
agarose in culture medium as described in MATERIALS AND
METHODS. After 21 d, colonies of120 m (16 cells) were counted.
(B) Dose response of H69 SCLC cell clonal growth to 4F2 (20 g/ml)
in the presence of increasing concentrations of LY294002 (LY) as
shown. Results are expressed as mean  SEM colonies/dish of two
independent experiments performed in triplicate.
Figure 8. Effect of cross-linking CD98 on neuropeptide-stimulated
clonal growth in SCLC cells. H345, H510, and H69 SCLC cells were
plated in SITA medium containing 0.3% agarose, in the presence or
absence of either bombesin (10 nM) (BN), galanin (50 nM) (Gal),
bradykinin (10 nM) (BK), and 4F2 (20 g/ml), over a base of 0.5%
agarose in culture medium as described in MATERIALS AND
METHODS. After 21 d, colonies of120 m (16 cells) were counted.
Results are expressed as mean  SEM colonies/dish of three inde-
pendent experiments performed in triplicate.
Figure 6. Cross-linking CD98 does not effect amino acid transport.
H69, H345, and H510 SCLC cells in amino acid- and Na-free buffer
were treated for 10 min with or without 4F2 (20 g/ml) in the
presence or absence of 5 mM BCH. [3H]Leucine uptake was mea-
sured as described in MATERIALS AND METHODS. Data are
expressed as percentage of control cells and are the means  SEM
of three independent experiments performed in triplicate. *p  0.05
compared with control cells.
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further modest increase in PKB phosphorylation. However,
CD98 overexpression in the GD251-null cells did not stim-
ulate PKB phosphorylation, confirming that 1 integrin ex-
pression was necessary for CD98 signaling. Furthermore,
overexpression of CD98 in GD251AY783/795F cells did not
stimulate PKB phosphorylation (Figure 9B). The results for
the GD251 cells were quantified by densitometry (Figure
9D). Phospho PKB and phospho FAK expression were sig-
nificantly higher in the CD98 transfected cells compared
with control cells and furthermore cross-linking with 4F2
caused a significant increase in phospho PKB and phospho
FAK expression over the CD98 transfected cells. These re-
sults suggest that CD98 signaling through the PI 3-kinase/
PKB pathway is dependent on a functional 1 integrin and
may be FAK dependent.
DISCUSSION
In this study, we have examined the interaction between
CD98 and 1 integrin in nonpolarized, nonadherent cells,
which are transformed and lack an organized cytoskeleton.
We demonstrate the following: 1) CD98 and 1 integrin are
constitutively colocalized, regardless of integrin activation
state and cell polarization. 2) Cross-linking CD98 can stim-
ulate integrin-like signaling in the absence of integrin liga-
tion or extracellular matrix engagement and furthermore
can promote anchorage-independent growth. 3) The pres-
ence of 1 integrin is necessary for CD98 intracellular sig-
naling.
Recent work suggests that CD98 may be important in
cancer, inflammation, and viral disease through its effects on
Figure 9. CD98 signaling is 1 integrin and
FAK dependent. (A) Flow cytometric analysis
of 1 integrin and CD98 expression (solid
black line) and IgG1 and IgG2a negative con-
trol antibodies respectively (hatched line) in
GD25 1 integrin null cells, wild-type GD25
1 integrin cells, and mutant GD25Y783/795F
cells. (B) GD25 1 integrin null, wild-type
GD251, and GD25Y783/795F cells were tran-
siently transfected with CD98 or control vec-
tor and treated in the presence or absence of
4F2 (20 g/ml) or fetal calf serum (FCS) (10%
for 10 min) as positive control. Cell lysates
were Western blotted and probed with an
antibody, which recognizes PKB or phos-
phorylation of PKB at serine 473 (PKB-P). (C)
Wild-type GD251 were transiently trans-
fected with CD98 or control vector and
treated in the presence or absence of 4F2 (20
g/ml) or FCS as described above. Cell ly-
sates were Western blotted and probed with
an antibody, that recognizes FAK or phos-
phorylated FAK. Representative blots from
experiments performed in duplicate, three
times, are shown. (D) Densitometric analysis
of GD251 phospho PKB, and phospho FAK
blots was undertaken as described in MATE-
RIALS AND METHODS. Results are ex-
pressed as percentage maximum expression
(FCS). *p  0.05 compared with control cells;
**p  0.05 compared with CD98-transfected
cells.
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cellular activation and integrin-mediated adhesion. Despite
being implicated in an extraordinary diversity of functions
its mechanism of action has not been fully elucidated. There
is now good evidence that the heavy chain, which dimerizes
with up to six alternative light chains, is important in regu-
lating amino acid transport (Quackenbush et al., 1987; Teix-
eira et al., 1987; Warren et al., 1996; Kanai et al., 1998; Mas-
troberardino et al., 1998; Nakamura et al., 1999).
Furthermore, there is evidence that CD98 plays an important
role in regulating integrin affinity (Fenczik et al., 1997). Al-
though a functional association between CD98 and 1 inte-
grin in the cell membrane has been described previously
(Fenczik et al., 1997; Warren et al., 2000; Cho et al., 2001), until
recently there was no clear data showing physiological in-
teraction between CD98 and 1 integrin. Recently, Zent et al.
(2000) have shown that CD98 can associate with isolated
cytoplasmic portions of some 1 integrin isoforms. Using an
anchorage-dependent intestinal epithelial cell layer model,
Merlin et al. (2001) demonstrated that CD98 could be coim-
munoprecipitated with both 1 integrin and the L-amino
acid transporter-2) and that all three proteins were polarized
to the basolateral domain. Furthermore, Kolesnikova et al.
(2001) have recently shown that CD98 constitutively and
specifically associated with various 1 integrin subunits.
Our findings confirm and extend these results and show that
on anchorage-independent nonpolarized cells, CD98 and 1
integrin coimmunoprecipitate and under physiological con-
ditions are colocalized irrespective of activation state. This
finding has implications for our understanding of the mech-
anisms underlying cell migration and adhesion that are
central not only to tumor metastasis but also to a range of
physiological processes such as embryogenesis, hemostasis,
and the immune response. Cross-linking CD98 has been
shown to stimulate 1-dependent tumor cell adhesion to
extracellular matrix proteins (Fenczik et al., 1997; Chan-
drasekaran et al., 1999). Although ubiquitous, CD98 expres-
sion is up-regulated on a variety of anchorage-independent
cell types, including hematopoietic cells and most human
tumor cells (Azzarone et al., 1985). This up-regulation may
be important for modulating the changes in integrin affinity
and avidity state required to regulate the processes of adhe-
sion and de-adhesion required for cell migration.
The second major finding from this study is that cross-
linking CD98 stimulates PI 3-kinase, as well as its product
PI(3,4,5)P3, and its downstream effector, PKB. Until now, the
mechanism of action of CD98 has been unclear. It has been
shown previously that tyrosine kinase activation mediates
CD98 induced homotypic aggregation of lymphoid progen-
itor cells (Ito et al., 1992; Warren et al., 1996). We examined PI
3-kinase as a likely candidate for CD98-mediated intracellu-
lar signaling because it can be activated by the majority of
receptors with intrinsic or associated tyrosine kinase activity
and by receptors linked to heterotrimeric G proteins.
The finding that treatment with 4F2 activated PI 3-kinase,
PI(3,4,5)P3, and PKB in a PI 3-kinase-dependent manner
suggests that cross-linking CD98 promotes “integrin-like”
intracellular signaling. We confirmed that cross-linking of
CD98 was necessary, by showing that monoclonal 4F2-Fab
fragments, which are unable to cross-link CD98, did not
have any effect on kinase activation. However, cross-linking
of 4F2-Fab with an anti-Fab antibody restored CD98 signal-
ing capability. Furthermore, preincubation with 4F2-Fab an-
tibody blocked subsequent 4F2 stimulation of PI 3-kinase
supporting this hypothesis. Importantly, IgG2A isotype
matched control antibody to the transferrin receptor (CD71),
which is well expressed on SCLC cells, failed to activate PI
3-kinase or increase PI(3,4,5)P3 levels. Taken together, these
results indicate that it is the specific cross-linking of CD98
heavy chain that is required for activation of intracellular
signaling. Cross-linking the heavy chain of CD98 had no
effect on amino acid transport. In addition, the use of the
L-system amino acid transport blocking agent BCH had no
effect on 4F2-mediated intracellular signaling, suggesting
that CD98 light chain, which has been implicated in amino
acid transport, does not play a direct role in this process.
This is entirely in keeping with previous published results
that have shown that integrin activation by CD98 is inde-
pendent of its amino acid transport function (Zent et al.,
2000; Merlin et al., 2001).
Our results demonstrate that the presence of wild-type 1
integrin is necessary for CD98 signaling. The role of 1
integrins in CD98 signaling was examined. CD98 was trans-
fected into fibroblasts derived from 1 null stem cells
(GD25), GD25 cells expressing wild-type 1, or GD25 cells
expressing 1 integrin subunits with point mutations of the
cytoplasmic domain Y783/Y795F, which impairs FAK ty-
rosine phosphorylation and activation in response to 1-
dependent adhesion compared with wild type. Overexpres-
sion of CD98 in the wild-type 1 integrin cells was sufficient
to promote PKB and FAK phosphorylation. This was also
observed in CD98-transfected CHO cells. Overexpression of
CD98 is sufficient to rescue 1 integrin from tac-1-mediated
integrin suppression (Fenczik et al., 1997), and transform
NIH3T3 cells (Hara et al., 1999). We propose that this is due
to clustering of overexpressed CD98. Further cross-linking
of CD98 with 4F2 caused an additional significant increase
in both PKB and FAK phosphorylation. The fact that FAK
phosphorylation is promoted by cross-linking CD98 in
GD25 1 wild-type cells but not in GD25 cells expressing the
1 Y783/Y795F mutant integrin, suggests that CD98 signal-
ing may be mediated through a 1 integrin/FAK axis. How-
ever, it is possible that the 1 Y783/Y795F mutant integrin is
defective in other signals in addition to FAK. GD25 cells
express other integrins apart from 1 that can activate FAK
(e.g., 3 integrins). Overexpressing (and cross-linking) CD98
in the null cells did not stimulate PKB or FAK phosphory-
lation, suggesting that there is some specificity toward 1
integrins in stimulating signal transduction. Indeed, in vitro
binding studies have shown that CD98 heavy chain interacts
specifically with the integrin 1A but not with 1D or 7
cytoplasmic domain (Zent et al., 2000). In addition, there
may also be  subunit specificity, for example CD98-induces
clustering of 31 but not 41 (Kolesnikova et al., 2001).
We have also shown that cross-linking CD98 promoted
anchorage-independent growth. The ability of cells to grow
in soft agar is a feature of anchorage independence and
pathognomonic of the transformed phenotype, correlating
with tumorigenicity and invasiveness of the tumor (Carney
et al., 1980). PI 3-kinase acting through PKB has been shown
to promote anchorage-independent growth (Moore et al.,
1998). There is now increasing evidence that CD98 has on-
cogenic potential. Hara et al., (1999) showed that human
CD98 transfected NIH3T3 cells were capable of anchorage-
independent growth and that CD98 transfected clones led to
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tumor development in athymic mice. Our results showing
that cross-linking CD98 promotes anchorage-independent
growth supports this idea. It has previously been shown that
constitutively active PI 3-kinase can transform chick embryo
fibroblasts (Chang et al., 1997) and that a mutant p85 can
transform fibroblasts in vitro (Jimenez et al., 1998). Further-
more, integrin-mediated PI 3-kinase activation seems to be
important for cell migration and can promote carcinoma
invasion (Keely et al., 1997; Renshaw et al., 1997). Constitu-
tive activation of PI 3-kinase as a result of overexpression of
CD98 may explain the transformation seen in CD98-trans-
fected NIH3T3 cells.
Full oncogenic transformation is believed to require both
serum- and anchorage-independent growth (Schwartz,
1997). SCLC cell growth is promoted by multiple autocrine
and paracrine growth loops involving calcium mobilizing
neuropeptides (Sethi and Rozengurt, 1991), which activate
MAP kinase through G protein-coupled receptors (Seuffer-
lein and Rozengurt, 1996). Recent work suggests that for full
activation of the MAP kinase pathway by growth factors an
integrin-mediated cosignal is required (Renshaw et al., 1997).
The finding that CD98 augments neuropeptide-mediated
SCLC colony growth supports this hypothesis. Therefore,
we propose that cross-linking CD98 mimics inte-
grin-dependent signal transduction and may facilitate neu-
ropeptide-mediated cell growth.
It now seems that CD98 is a multifunctional molecule: cell
fusion regulator, amino acid transporter, comitogen, and
now an integrin regulator and an oncogenic protein. In
summary, we propose that by cross-linking CD98, it acts as
a “molecular facilitator” in the plasma membrane, clustering
1 integrins to form high-density complexes. This results in
integrin activation and adhesion, integrin signaling, and
anchorage-independent growth. In particular, CD98 has
been shown to stimulate 1 integrin-mediated cell adhesion
to extracellular matrix (Fenczik et al., 1997). We propose that
this may occur as a result of both affinity and avidity
changes. CD98 has been shown to reverse tac-1 suppres-
sion, increasing integrin affinity; this may occur as a result of
cell signaling and/or conformational changes. In addition,
the clustering of integrins by CD98 will increase binding
avidity. Further understanding of the mechanism of action
of CD98 may facilitate our knowledge of the mechanisms
that regulate cell adhesion, migration, and metastasis. Fur-
thermore, this information may provide a paradigm for
events involved in such diverse processes as inflammation
and viral-induced cell fusion.
ACKNOWLEDGMENTS
We gratefully acknowledge Linda Sharp (University of Edinburgh
Medical School confocal facility) for expert technical assistance and
Judith Gordon (University of Edinburgh Medical School) for secre-
tarial support. This work was supported by the Medical Research
Council, UK (Clinical Training Fellowships to R.C.R. and R.C.B.)
and the Wellcome Trust.
REFERENCES
Azzarone, B., Malpiece, Y., Zaech, P., Moretta, L., Fauci, A., and
Suarez, H. (1985). Analysis of the expression of the 4F2 surface
antigen in normal and neoplastic fibroblastic human cells of embry-
onic and adult origin. Exp. Cell Res. 159, 451–462.
Bellacosa, A., Testa, J.R., Staal, S.P., and Tsichlis, P.N. (1991). A
retroviral oncogene, Akt, encoding a serine-threonine kinase con-
taining an SH2-like region. Science 254, 274–277.
Bellone, G., Alloatti, G., Levi, R., Geuna, M., Tetta, C., Peruzzi, L.,
Letarte, M., and Malavasi, F. (1989). Identification of a new epitope
of the 4F2/44D7 molecular complex present on sarcolemma and
isolated cardiac fibers. Eur. J. Immunol. 19, 1–8.
Carney, D.N., Gazdar, A.F., and Minna, J.D. (1980). Positive corre-
lation between histological tumor involvement and generation of
tumor cell colonies in agarose in specimens taken directly from
patients with small-cell carcinoma of the lung. Cancer Res. 40,
1820–1823.
Carpenter, C.L., and Cantley, L.C. (1996). Phosphoinositide kinases.
Curr. Opin. Cell Biol. 8, 153–158.
Chandrasekaran, S., Guo, N.H., Rodrigues, R.G., Kaiser, J., and
Roberts, D.D. (1999). Proadhesive and chemotactic activities of
thrombospondin-1 for breast carcinoma cells are mediated by 31
integrin and regulated by insulin-like growth factor-1 and CD98.
J. Biol. Chem. 274, 11408–11416.
Chang, H.W., Aoki, M., Fruman, D., Auger, K.R., Bellacosa, A.,
Tsichlis, P.N., Cantley, L.C., Roberts, T.M., and Vogt, P.K. (1997).
Transformation of chicken cells by the gene encoding the catalytic
subunit of PI 3-kinase. Science 276, 1848–1850.
Cho, J.Y., Fox, D.A., Horejsi, V., Sagawa, K., Skubitz, K.M., Katz,
D.R., and Chain, B. (2001). The functional interactions between
CD98, -1 integrins and Cd147 in the induction of U937 homotypic
aggregation. Blood 98, 374–382.
Dixon, W.T., Sikora, L.K., Demetrick, D.J., and Jerry, L.M. (1990).
Isolation and characterization of a heterodimeric surface antigen on
human melanoma cells and evidence that it is the 4F2 cell activa-
tion/proliferation molecule. Int. J. Cancer 45, 59–68.
Fassler, R., Pfaff, M., Murphy, J., Noegel, A.A., Johansson, S., Timpl,
R., and Albrecht, R. (1995). Lack of 1 integrin gene in embryonic
stem cells affects morphology, adhesion, and migration but not
integration into the inner cell mass of blastocysts. J. Cell Biol. 128,
979–988.
Fenczik, C.A., Sethi, T., Ramos, J.W., Hughes, P.E., and Ginsberg,
M.H. (1997). Complementation of dominant suppression implicates
CD98 in integrin activation. Nature 390, 81–85.
Freidman, A.W., Diaz, L.A., Jr., Moore, S., Schaller, J., and Fox, D.A.
(1994). The human 4F2 antigen: evidence for cryptic and noncryptic
epitopes and for a role of 4F2 in human T lymphocyte activation.
Cell Immunol. 154, 253–263.
Hara, K., Kudoh, H., Enomoto, T., Hashimoto, Y., and Masuko, T.
(1999). Malignant transformation of NIH3T3 cells by overexpression
of early lymphocyte activation antigen CD98. Biochem. Biophys.
Res. Commun. 262, 720–725.
Haynes, B.F., Hemler, M.E., Mann, D., Eisenbarth, G., Shelhamer, J.,
Mostowski, H.S., Thomas, C.A., Strominger, J.L., and Fauci, A.
(1981). Characterization of a monoclonal antibody (4F2) that binds
to human monocytes and to a subset of activated lymphocytes.
J. Immunol. 126, 1409–1414.
Ito, Y., Komada, H., Kusagawa, S., Tsurudome, M., Matsumura, H.,
Kawano, M., Ohta, H., and Nishio, M. (1992). Fusion regulation
proteins on the cell surface: isolation and characterization of mono-
clonal antibodies which enhance giant polykaryocyte formation in
Newcastle disease virus-infected cell lines of human origin. J. Virol.
66, 5999–6007.
Jimenez, C., et al. (1998). Identification and characterization of a new
oncogene derived from the regulatory subunit of phosphoinositide
3-kinase. EMBO J. 17, 743–753.
CD98 Stimulates Integrin-like Signaling
Vol. 13, August 2002 2851
Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., and
Endou, H. (1998). Expression cloning and characterization of a
transporter for large neutral amino acids activated by the heavy
chain of 4F2 antigen (CD98). J. Biol. Chem. 273, 23629–23632.
Keely, P.J., Westwick, J.K., Whitehead, I.P., Der, C.J., and Parise,
L.V. (1997). Cdc42 and Rac1 induce integrin-mediated cell motility
and invasiveness through PI(3)K. Nature 390, 632–636.
King, W.G., Mattaliano, M.D., Chan, T.O., Tsichlis, P.N., and
Brugge, J.S. (1997). Phosphatidylinositol 3-kinase is required for
integrin-stimulated AKT and Raf-1/mitogen-activated protein ki-
nase pathway activation. Mol. Cell. Biol. 17, 4406–4418.
Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H., and
Downward, J. (1997). Matrix adhesion and Ras transformation both
activate a phosphoinositide 3-OH kinase and protein kinase B/Akt
cellular survival pathway. EMBO J. 16, 2783–2793.
Kolesnikova, T.V., Mannion, B., Berditchevski, F., and Hemler, M.E.
(2001). 1 integrins show specific association with CD98 protein in
low density membranes. BMC Biochem. 2, 10.
Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P.J., Loffing, J.,
Shoemaker, C.B., and Verrey, F. (1998). Amino-acid transport by
heterodimers of 4F2hc/CD98 and members of a permease family.
Nature 395, 288–291.
Merlin, D., Sitaraman, S., Liu, X., Eastburn, K., Sun, J., Kucharzik, T.,
Lewis, B., and Madara, J.L. (2001). CD98-mediated links between
amino acid transport and -1 integrin distribution in polarized
columnar epithelia. J. Biol. Chem. 276, 39282–39289.
Michalak, M., Quackenbush, E.J., and Letarte, M. (1986). Inhibition
of Na/Ca2 exchanger activity in cardiac and skeletal muscle
sarcolemmal vesicles by monoclonal antibody 44D7. J. Biol. Chem.
261, 92–95.
Moore, S.M., Rintoul, R.C., Walker, T.R., Chilvers, E.R., Haslett, C.,
and Sethi, T. (1998). The presence of a constitutively active phos-
phoinositide 3-kinase in small cell lung cancer cells mediates an-
chorage-independent proliferation via a protein kinase B and
p70s6k-dependent pathway. Cancer Res. 58, 5239–5247.
Nakamura, E., Sato, M., Yang, H., Miyagawa, F., Harasaki, M.,
Tomita, K., Matsuoka, S., Noma, A., Iwai, K., and Minato, N. (1999).
4F2 (CD98) heavy chain is associated covalently with an amino acid
transporter and controls intracellular trafficking and membrane to-
pology of 4F2 heterodimer. J. Biol. Chem. 274, 3009–3016.
Ohgimoto, S., Tabata, N., Suga, S., Nishio, M., Ohta, H., Tsurudome,
M., Komada, H., Kawano, M., and Watanabe, Y. (1995). Molecular
characterization of fusion regulatory protein-1 (FRP-1) that induces
multinucleate formation of monocytes and HIV gp160-mediated cell
fusion. FRP-1 and 4F2/CD98 are identical. J. Immunol. 155, 3585–
3592.
Okamoto, K., Ohgimoto, S., Nishio, M., Tsurudome, M., Kawano,
M., Komada, H., Ito, M., Sakakura, Y., and Ito, Y. (1997). Paramyxo-
virus-induced syncytium cell formation is suppressed by a domi-
nant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated
construct: an important role of FRP-1 in virus-induced cell fusion.
J. Gen. Virol. 78, 775–783.
Parmacek, M.S., Karpinski, B.A., Gottesdiener, K.M., Thompson,
C.B., and Leiden, J.M. (1989). Structure, expression and regulation of
the murine 4F2 heavy chain. Nucleic Acids Res. 17, 1915–1931.
Posillico, J.T., Srikanta, S., Eisenbarth, G., Quaranta, V., Kajiji, S., and
Brown, E.M. (1987). Binding of monoclonal antibody (4F2) to its cell
surface antigen on dispersed adenomatous parathyroid cells raises
cytosolic calcium and inhibits parathyroid hormone secretion.
J. Clin. Endocrinol. Metab. 64, 43–50.
Quackenbush, E., Clabby, M., Gottesdiener, K.M., Barbosa, J., Jones,
N.H., Strominger, J.L., Speck, S., and Leiden, J.M. (1987). Molecular
cloning of complementary DNAs encoding the heavy chain of the
human 4F2 cell-surface antigen: a type II membrane glycoprotein
involved in normal and neoplastic cell growth. [published erratum
appears in Proc. Natl. Acad. Sci. USA (1987) 84, 8618]. Proc. Natl.
Acad. Sci. USA 84, 6526–6530.
Renshaw, M.W., Ren, X.D., and Schwartz, M.A. (1997). Growth
factor activation of MAP kinase requires cell adhesion. EMBO J. 16,
5592–5599.
Sakai, T., Zhang, Q., Fassler, R., and Mosher, D. (1998). Modulation
of 1A integrin functions by tyrosine residues in the 1 cytoplasmic
domain. J. Cell Biol. 141, 527–538.
Schwartz, M.A. (1997). Integrins, oncogenes, and anchorage inde-
pendence. J. Cell Biol. 139, 575–578.
Sethi, T., and Rozengurt, E. (1991). Multiple neuropeptides stimu-
late clonal growth of small cell lung cancer: effects of bradykinin,
vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res.
51, 3621–3623.
Seufferlein, T., and Rozengurt, E. (1996). Galanin, neurotensin, and
phorbol esters rapidly stimulate activation of mitogen-activated
protein kinase in small cell lung cancer cells. Cancer Res. 56, 5758–
5764.
Suomalainen, H.A. (1986). The monoclonal antibodies Trop-4 and
4F2 detect the same membrane antigen that is expressed at an early
stage of lymphocyte activation and is retained on secondary lym-
phocytes. J. Immunol. 137, 422–427.
Tabata, N., et al. (1997). Protein tyrosine kinase activation provides
an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal
antibody induced cell fusion mediated by HIV gp160. Med. Micro-
biol. Immunol. 186, 115–123.
Teixeira, S., Di Grandi, S., and Kuhn, L.C. (1987). Primary structure
of the human 4F2 antigen heavy chain predicts a transmembrane
protein with a cytoplasmic NH2 terminus. J. Biol. Chem. 262, 9574–
9580.
vanderKaayJ.,Cullen,P.J.,andDownes,C.P.(1999).Phosphatidylino-
sitol (3,4,5) trisphosphate mass measurement using a radioligand
displacement assay. In: Phospholipid Signaling Protocols, ed. I.M.
Bird, Totowa, NJ: Humana Press, 109–125.
Verrey, F., Jack, D.L., Paulsen, I.T., Saier, M.H., and Pfeiffer, R.
(1999). New glycoprotein-associated amino acid transporters. J.
Membr. Biol. 172, 181–192.
Warren, A.P., Patel, K., McConkey, D.J., and Palacios, R. (1996).
CD98: a type II transmembrane glycoprotein expressed from the
beginning of primitive and definitive hematopoiesis may play a
critical role in the development of hematopoietic cells. Blood 87,
3676–3687.
Warren, A.P., Patel, K., Miyamoto, Y., Wygant, J.N., Woodside,
D.G., and McIntyre, B.W. (2000). Convergence between CD98 and
integrin-mediated T-lymphocyte co-stimulation. Immunology 99,
62–68.
Wennerberg, K., Armulik, A., Sakai, T., Karlsson, M., Fassler, R.,
Schaefer, E.M., Mosher, D., and Johansson, S. (2000). The cytoplas-
mic tyrosines of integrin subunit 1 are involved in focal adhesion
kinase activation. Mol. Cell. Biol. 20, 5758–5765.
Zent, R., Fenczik, C.A., Calderwood, D.A., Liu, S., Dellos, M., and
Ginsberg, M.H. (2000). Class and splice variant-specific association
of CD98 with integrin  cytoplasmic domains. J. Biol. Chem. 275,
5059–5064.
R.C. Rintoul et al.
Molecular Biology of the Cell2852
